The present disclosure relates to providing an engineered CHO
cell line wherein the two essential metabolic genes are knocked out. Particularly, the present invention relates to a double knockout CHO
cell line (DHFR− / − and GS− / −) with disrupted
Dihydrofolate Reductase (DHFR) and
Glutamine Synthetase (GS) genomic loci. The double knockout CHO
cell line (DHFR− / − and GS− / −) being suitable for expression of
monoclonal antibodies, dimeric therapeutic proteins, Fab,
single chain fragments, or the like. The present disclosure also provides method of generation of a double knock out CHO cell line (DHFR− / − and GS− / −) using
gene selection and / or manipulating techniques such as
CRISPR / Cas9
system,
Zinc Finger
Nuclease, TALEN, or the like. The present disclosure further provides method of selection of clones and production of therapeutic proteins of interest with increased titre.